Meg M. Silverman

Meg M. Silverman

Plus aucun poste en cours

Finance
Health Technology

Profil

Ms. Meg M.
Silverman
is Head of Investor Relations at Thomas, McNerney & Partners LLC.
She joined the firm in 2010.
She has extensive experience in the venture capital industry.
Previously, she was Partner-US Investor Relations at Advent Ventures Life Sciences, and before that she spent thirteen years at HealthCare Ventures LLC, previously as Director of LP Relations and Director of Administration.
While at Advent and HealthCare, she was instrumental in raising over $800 million.
Ms. Silverman has a wide-ranging knowledge of the biotechnology industry, including an in-depth understanding of pharmaceutical clinical research and regulatory filings, having concentrated on these areas earlier in her career at The Liposome Company, Inc., a publicly traded biotechnology company subsequently acquired by Elan; Biodecision Incorporated, a clinical research organization; and Shadyside Hospital, a major teaching and research hospital.

Anciens postes connus de Meg M. Silverman

SociétésPosteFin
Public Communications Contact 31/08/2011
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Meg M. Silverman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Meg M. Silverman

Relations

1

Relations au 1er degré

3

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées3

Finance

Finance

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Meg M. Silverman